Literature DB >> 23040566

Elevated pre-operative serum peptides for collagen I and III synthesis result in post-surgical atrial fibrillation.

Michael F Swartz1, Gregory W Fink, Muhammad F Sarwar, George L Hicks, Yao Yu, Rui Hu, Charles J Lutz, Steven M Taffet, José Jalife.   

Abstract

OBJECTIVES: This study sought to determine if serum markers for collagen I and III synthesis, the carboxyl terminal peptide from pro-collagen I (PICP) and the amino terminal peptide from pro-collagen III (PIIINP), correlate with left atrial (LA) fibrosis and post-operative atrial fibrillation (AF).
BACKGROUND: AF after cardiac surgery is associated with adverse outcomes. We recently demonstrated that LA fibrosis is associated with post-operative AF in patients with no previous history of AF.
METHODS: Fifty-four patients having cardiac surgery without a history of AF consented to left and right atrial biopsies and a pre-operative peripheral blood draw. Picrosirius red staining quantified the percentage of fibrosis, and reverse transcriptase polymerase chain reaction assessed atrial tissue messenger ribonucleic acid transcripts involved in the fibrosis pathway. PICP and PIIINP levels were measured using an enzyme immunosorbent assay.
RESULTS: Eighteen patients developed AF, whereas 36 remained in normal sinus rhythm. LA fibrosis was higher in patients who developed AF versus normal sinus rhythm (6.13 ± 2.9% vs. 2.03 ± 1.9%, p = 0.03). LA messenger ribonucleic acid transcripts for collagen I, III, transforming growth factor, and angiotensin were 1.5- to 2.0-fold higher in AF patients. Serum PICP and PIIINP levels were highest in AF versus normal sinus rhythm (PICP: 451.7 ± 200 ng/ml vs. 293.3 ± 114 ng/ml, p = 0.006; PIIINP: 379 ± 286 pg/ml vs. 191.6 ± 162 pg/ml, p = 0.01). Furthermore, there was a linear correlation between LA fibrosis and serum PICP levels (R(2) = 0.2; p = 0.01), and of the markers, only PICP was independently associated with AF.
CONCLUSIONS: This demonstrates that serum PICP and PIIINP levels correlate with the presence of LA fibrosis and may act as predictors for post-operative AF even in the absence of previous history of AF.
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23040566      PMCID: PMC3482337          DOI: 10.1016/j.jacc.2012.06.048

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  20 in total

1.  Impact of biomarkers of inflammation and extracellular matrix turnover on the outcome of atrial fibrillation ablation: importance of matrix metalloproteinase-2 as a predictor of atrial fibrillation recurrence.

Authors:  Yasuo Okumura; Ichiro Watanabe; Toshiko Nakai; Kimie Ohkubo; Tatsuya Kofune; Masayoshi Kofune; Koichi Nagashima; Hiroaki Mano; Kazumasa Sonoda; Yuji Kasamaki; Atsushi Hirayama
Journal:  J Cardiovasc Electrophysiol       Date:  2011-04-13

2.  Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease.

Authors:  R Querejeta; N Varo; B López; M Larman; E Artiñano; J C Etayo; J L Martínez Ubago; M Gutierrez-Stampa; J I Emparanza; M J Gil; I Monreal; J P Mindán; J Díez
Journal:  Circulation       Date:  2000-04-11       Impact factor: 29.690

3.  Identification of a potential cardiac antifibrotic mechanism of torasemide in patients with chronic heart failure.

Authors:  Begoña López; Arantxa González; Javier Beaumont; Ramón Querejeta; Mariano Larman; Javier Díez
Journal:  J Am Coll Cardiol       Date:  2007-08-13       Impact factor: 24.094

Review 4.  Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation.

Authors:  Brett Burstein; Stanley Nattel
Journal:  J Am Coll Cardiol       Date:  2008-02-26       Impact factor: 24.094

5.  Effect of angiotensin-converting enzyme insertion/deletion genotype on collagen type I synthesis and degradation in patients with atrial fibrillation and arterial hypertension.

Authors:  Dimitrios N Tziakas; Georgios K Chalikias; Dimitrios A Stakos; Dimitrios Papazoglou; Nikolaos Papanas; Konstantinos Papatheodorou; Sofia V Chatzikyriakou; Stamatia Kotsiou; Efstratios Maltezos; Harisios Boudoulas
Journal:  Expert Opin Pharmacother       Date:  2007-10       Impact factor: 3.889

6.  Extracellular matrix alterations in patients with paroxysmal and persistent atrial fibrillation: biochemical assessment of collagen type-I turnover.

Authors:  Eleftherios M Kallergis; Emmanuel G Manios; Emmanuel M Kanoupakis; Hercules E Mavrakis; Dimitris A Arfanakis; Niki E Maliaraki; Chrisovalantis E Lathourakis; Gregory I Chlouverakis; Panos E Vardas
Journal:  J Am Coll Cardiol       Date:  2008-07-15       Impact factor: 24.094

7.  Left versus right atrial difference in dominant frequency, K(+) channel transcripts, and fibrosis in patients developing atrial fibrillation after cardiac surgery.

Authors:  Michael F Swartz; Gregory W Fink; Charles J Lutz; Steven M Taffet; Omer Berenfeld; Karen L Vikstrom; Kimberly Kasprowicz; Luna Bhatta; Ferenc Puskas; Jérôme Kalifa; José Jalife
Journal:  Heart Rhythm       Date:  2009-06-17       Impact factor: 6.343

8.  Spatial distribution of fibrosis governs fibrillation wave dynamics in the posterior left atrium during heart failure.

Authors:  Kazuhiko Tanaka; Sharon Zlochiver; Karen L Vikstrom; Masatoshi Yamazaki; Javier Moreno; Matthew Klos; Alexey V Zaitsev; Ravi Vaidyanathan; David S Auerbach; Steve Landas; Gérard Guiraudon; José Jalife; Omer Berenfeld; Jérôme Kalifa
Journal:  Circ Res       Date:  2007-08-17       Impact factor: 17.367

9.  Cellular electrophysiologic properties of old canine atria provide a substrate for arrhythmogenesis.

Authors:  Evgeny P Anyukhovsky; Eugene A Sosunov; Alexei Plotnikov; Ravil Z Gainullin; Jeffrey S Jhang; Charles C Marboe; Michael R Rosen
Journal:  Cardiovasc Res       Date:  2002-05       Impact factor: 10.787

10.  Systematic analysis of gene expression differences between left and right atria in different mouse strains and in human atrial tissue.

Authors:  Peter C Kahr; Ilaria Piccini; Larissa Fabritz; Boris Greber; Hans Schöler; Hans H Scheld; Andreas Hoffmeier; Nigel A Brown; Paulus Kirchhof
Journal:  PLoS One       Date:  2011-10-19       Impact factor: 3.240

View more
  26 in total

1.  Galectin 3 and incident atrial fibrillation in the community.

Authors:  Jennifer E Ho; Xiaoyan Yin; Daniel Levy; Ramachandran S Vasan; Jared W Magnani; Patrick T Ellinor; David D McManus; Steven A Lubitz; Martin G Larson; Emelia J Benjamin
Journal:  Am Heart J       Date:  2014-03-01       Impact factor: 4.749

2.  2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.

Authors:  Hugh Calkins; Gerhard Hindricks; Riccardo Cappato; Young-Hoon Kim; Eduardo B Saad; Luis Aguinaga; Joseph G Akar; Vinay Badhwar; Josep Brugada; John Camm; Peng-Sheng Chen; Shih-Ann Chen; Mina K Chung; Jens Cosedis Nielsen; Anne B Curtis; D Wyn Davies; John D Day; André d'Avila; N M S Natasja de Groot; Luigi Di Biase; Mattias Duytschaever; James R Edgerton; Kenneth A Ellenbogen; Patrick T Ellinor; Sabine Ernst; Guilherme Fenelon; Edward P Gerstenfeld; David E Haines; Michel Haissaguerre; Robert H Helm; Elaine Hylek; Warren M Jackman; Jose Jalife; Jonathan M Kalman; Josef Kautzner; Hans Kottkamp; Karl Heinz Kuck; Koichiro Kumagai; Richard Lee; Thorsten Lewalter; Bruce D Lindsay; Laurent Macle; Moussa Mansour; Francis E Marchlinski; Gregory F Michaud; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Ken Okumura; Douglas Packer; Evgeny Pokushalov; Matthew R Reynolds; Prashanthan Sanders; Mauricio Scanavacca; Richard Schilling; Claudio Tondo; Hsuan-Ming Tsao; Atul Verma; David J Wilber; Teiichi Yamane
Journal:  Heart Rhythm       Date:  2017-05-12       Impact factor: 6.343

Review 3.  Highlights of the year in JACC 2012.

Authors:  Anthony N DeMaria; Jeroen J Bax; Gregory K Feld; Barry H Greenberg; Jennifer L Hall; Mark A Hlatky; Wilbur Y W Lew; João A C Lima; Ehtisham Mahmud; Alan S Maisel; Sanjiv M Narayan; Steven E Nissen; David J Sahn; Sotirios Tsimikas
Journal:  J Am Coll Cardiol       Date:  2013-01-22       Impact factor: 24.094

4.  2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society.

Authors:  Hugh Calkins; Karl Heinz Kuck; Riccardo Cappato; Josep Brugada; A John Camm; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; John DiMarco; James Edgerton; Kenneth Ellenbogen; Michael D Ezekowitz; David E Haines; Michel Haissaguerre; Gerhard Hindricks; Yoshito Iesaka; Warren Jackman; José Jalife; Pierre Jais; Jonathan Kalman; David Keane; Young-Hoon Kim; Paulus Kirchhof; George Klein; Hans Kottkamp; Koichiro Kumagai; Bruce D Lindsay; Moussa Mansour; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Douglas L Packer; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Vivek Reddy; Jeremy N Ruskin; Richard J Shemin; Hsuan-Ming Tsao; David Wilber
Journal:  Heart Rhythm       Date:  2012-03-01       Impact factor: 6.343

5.  From changes in local RAAS to structural remodeling of the left atrium: A beautiful cycle in atrial fibrillation.

Authors:  Q Yongjun; S Huanzhang; Z Wenxia; T Hong; X Xijun
Journal:  Herz       Date:  2014-01-19       Impact factor: 1.443

Review 6.  Immunopathogenesis and biomarkers of recurrent atrial fibrillation following ablation therapy in patients with preexisting atrial fibrillation.

Authors:  John H Rosenberg; John H Werner; Gilman D Plitt; Victoria V Noble; Jordan T Spring; Brooke A Stephens; Aleem Siddique; Helenmari L Merritt-Genore; Michael J Moulton; Devendra K Agrawal
Journal:  Expert Rev Cardiovasc Ther       Date:  2018-12-29

7.  Atrial Myocyte NLRP3/CaMKII Nexus Forms a Substrate for Postoperative Atrial Fibrillation.

Authors:  Jordi Heijman; Azinwi Phina Muna; Tina Veleva; Cristina E Molina; Henry Sutanto; Marcel Tekook; Qiongling Wang; Issam H Abu-Taha; Marcel Gorka; Stephan Künzel; Ali El-Armouche; Hermann Reichenspurner; Markus Kamler; Viacheslav Nikolaev; Ursula Ravens; Na Li; Stanley Nattel; Xander H T Wehrens; Dobromir Dobrev
Journal:  Circ Res       Date:  2020-07-30       Impact factor: 17.367

Review 8.  2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.

Authors:  Hugh Calkins; Gerhard Hindricks; Riccardo Cappato; Young-Hoon Kim; Eduardo B Saad; Luis Aguinaga; Joseph G Akar; Vinay Badhwar; Josep Brugada; John Camm; Peng-Sheng Chen; Shih-Ann Chen; Mina K Chung; Jens Cosedis Nielsen; Anne B Curtis; D Wyn Davies; John D Day; André d'Avila; N M S Natasja de Groot; Luigi Di Biase; Mattias Duytschaever; James R Edgerton; Kenneth A Ellenbogen; Patrick T Ellinor; Sabine Ernst; Guilherme Fenelon; Edward P Gerstenfeld; David E Haines; Michel Haissaguerre; Robert H Helm; Elaine Hylek; Warren M Jackman; Jose Jalife; Jonathan M Kalman; Josef Kautzner; Hans Kottkamp; Karl Heinz Kuck; Koichiro Kumagai; Richard Lee; Thorsten Lewalter; Bruce D Lindsay; Laurent Macle; Moussa Mansour; Francis E Marchlinski; Gregory F Michaud; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Ken Okumura; Douglas Packer; Evgeny Pokushalov; Matthew R Reynolds; Prashanthan Sanders; Mauricio Scanavacca; Richard Schilling; Claudio Tondo; Hsuan-Ming Tsao; Atul Verma; David J Wilber; Teiichi Yamane
Journal:  Europace       Date:  2018-01-01       Impact factor: 5.214

9.  Novel fibro-inflammation markers in assessing left atrial remodeling in non-valvular atrial fibrillation.

Authors:  Osman Sonmez; Furkan U Ertem; Mehmet Akif Vatankulu; Ercan Erdogan; Abdurrahman Tasal; Sıtkı Kucukbuzcu; Omer Goktekin
Journal:  Med Sci Monit       Date:  2014-03-21

10.  Myocardial extracellular volume expansion and the risk of recurrent atrial fibrillation after pulmonary vein isolation.

Authors:  Tomas G Neilan; Francois-Pierre Mongeon; Ravi V Shah; Otavio Coelho-Filho; Siddique A Abbasi; John A Dodson; Ciaran J McMullan; Bobak Heydari; Gregory F Michaud; Roy M John; Ron Blankstein; Michael Jerosch-Herold; Raymond Y Kwong
Journal:  JACC Cardiovasc Imaging       Date:  2013-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.